By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Ingredients A-Z > Dangerous/banned > BMPEA

BMPEA

GMJ
Last updated: 02/06/2026 18:42
By
Prof. Giorgi Pkhakadze
Share
8 Min Read
SHARE

Medically reviewed by Prof. Giorgi Pkhakadze, MD, MPH, PhD — GMJ Editorial Board

5 min read|1,030 words

What is BMPEA?

BMPEA (beta-methylphenylethylamine) is a synthetic stimulant compound that has been found as an undisclosed ingredient in some dietary supplements, particularly pre-workout and weight loss products. Also known as β-methylphenylethylamine or 2-amino-1-phenylpropane, BMPEA is structurally similar to amphetamine and other controlled stimulants. Unlike natural supplement ingredients, BMPEA is not found in foods and has no established nutritional value or legitimate therapeutic use.

The compound gained regulatory attention when the FDA identified it in numerous dietary supplements between 2013 and 2015, despite manufacturers falsely claiming it was derived from natural sources like Acacia rigidula. BMPEA is not approved as a dietary ingredient and is considered an adulterant when found in supplements sold in the United States.

Health benefits & uses

Evidence grade: Limited to none

Submit Your Paper
GMJ_Submit_Banner

There are no established health benefits or legitimate therapeutic uses for BMPEA. The compound has not undergone proper clinical trials for safety or efficacy. While supplement manufacturers have marketed products containing BMPEA for weight loss, athletic performance enhancement, and energy boosting, these claims lack scientific support.

The limited research available on BMPEA focuses on its detection in supplements and potential health risks rather than any therapeutic applications. No peer-reviewed studies demonstrate beneficial effects, and regulatory agencies have not approved BMPEA for any medical or nutritional purpose.

How it works

BMPEA acts as a central nervous system stimulant with a mechanism of action similar to amphetamines. The compound appears to affect neurotransmitter systems, particularly dopamine and norepinephrine, though the exact pharmacological pathways have not been thoroughly studied in controlled research settings.

As a phenylethylamine derivative, BMPEA may increase heart rate, blood pressure, and metabolic rate. However, the lack of comprehensive pharmacological studies means its full spectrum of biological effects remains poorly understood, contributing to significant safety concerns.

Dosage

There is no safe or recommended dosage for BMPEA. The compound is not approved for human consumption, and no regulatory agency has established safe intake levels. Products found to contain BMPEA have shown highly variable concentrations, often without disclosure on product labels.

Healthcare providers strongly advise against using any products containing BMPEA. Consumers should avoid supplements that list BMPEA or its synonyms as ingredients, as well as products making unsubstantiated claims about “natural” stimulants from sources like Acacia rigidula.

Food sources

BMPEA does not occur naturally in foods. Claims by some supplement manufacturers that BMPEA is naturally derived from plants like Acacia rigidula have been debunked by scientific analysis. The compound is synthetically produced and has no natural dietary sources.

Consumers should be aware that legitimate, naturally-occurring phenylethylamine compounds found in small amounts in foods like chocolate are structurally different from BMPEA and do not pose the same safety concerns.

Safety & side effects

BMPEA poses significant safety risks and has been linked to serious adverse events. Potential side effects include cardiovascular complications such as elevated heart rate, increased blood pressure, chest pain, and cardiac arrhythmias. Neurological effects may include anxiety, agitation, headaches, and in severe cases, seizures.

The FDA has received reports of serious adverse events associated with supplements containing BMPEA, including hospitalizations and emergency room visits. The compound’s structural similarity to controlled stimulants raises concerns about abuse potential and long-term health effects.

Due to the lack of safety studies and quality control in products containing BMPEA, the full range of potential side effects and long-term health consequences remains unknown.

Interactions

BMPEA may interact dangerously with numerous medications and other supplements. Potential interactions include amplified effects when combined with other stimulants, dangerous blood pressure elevations when taken with certain antidepressants (particularly MAOIs), and complications with cardiovascular medications.

The compound may also interact with caffeine and other stimulant ingredients commonly found in dietary supplements, potentially leading to serious cardiovascular and neurological effects. Due to limited research, the full scope of potential interactions remains unknown.

Who should be cautious

Everyone should avoid BMPEA-containing products, but certain populations face particularly high risks. Individuals with cardiovascular conditions, hypertension, diabetes, anxiety disorders, or seizure disorders should be especially cautious. Pregnant and breastfeeding women should strictly avoid any products that might contain BMPEA.

Athletes should be aware that BMPEA may be prohibited by anti-doping agencies and could result in positive drug tests. Individuals taking any prescription medications should consult healthcare providers before using any supplements, particularly those marketed for weight loss or athletic performance enhancement.

Frequently asked questions

Is BMPEA legal in dietary supplements?

No, BMPEA is not legal as a dietary supplement ingredient in the United States. The FDA considers it an adulterant and has issued warning letters to companies selling products containing BMPEA.

How can I tell if a supplement contains BMPEA?

BMPEA is often not listed on supplement labels. Be cautious of products claiming to contain “natural” stimulants from Acacia rigidula or making exaggerated performance claims. Choose products from reputable manufacturers that undergo third-party testing.

What should I do if I’ve taken a supplement containing BMPEA?

Stop using the product immediately and consult a healthcare provider, especially if you experience any adverse effects. Report serious side effects to the FDA’s MedWatch program.

Are there safe alternatives to BMPEA for energy and performance?

Yes, consider evidence-based alternatives like caffeine, creatine, or beta-alanine for performance enhancement. Always consult healthcare providers before starting any supplement regimen.

How widespread is BMPEA contamination in supplements?

Studies have found BMPEA in numerous supplement products, particularly pre-workout and weight loss formulations. The problem appears to be ongoing despite regulatory efforts, highlighting the importance of choosing carefully vetted products.

Classification:

Typical dose: — · Studied up to: —

References

Authoritative profile & live regulatory status: BMPEA on SupplementIndex →

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
The 30-gram protein myth: why recent evidence challenges the fitness industry’s most durable claim

For over a decade, the fitness industry has promoted a rule: your…

How the gut absorbs nutrients with molecular precision: A seven-meter biochemical assembly line

The human gastrointestinal tract functions as a seven-meter nutrient-extraction assembly line, with…

Why Thiamine Deficiency Is Silent but Serious in Heart Failure Patients

Loop diuretics—the standard treatment for heart failure—deplete thiamine, the essential cofactor for…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

SARMs

By
Prof. Giorgi Pkhakadze
02/06/2026

Yellow Oleander (in Tejocote)

By
Prof. Giorgi Pkhakadze
02/06/2026

Methylsynephrine / Oxilofrine

By
Prof. Giorgi Pkhakadze
02/06/2026

Nux Vomica / Strychnine

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up